Skip to main content
Watch Insiders
GLUE filings

Corporate insider profile

Sharon Townson Filing Activity

Latest reported as Chief Scientific Officer of Monte Rosa Therapeutics, Inc. (GLUE).

Purchase filings
0
Reported companies
1
Net open-market value
-$236,220.00
Latest transaction
Jun 23, 2026

Affiliated corporations

Reported company relationships

GLUELatest reported

Monte Rosa Therapeutics, Inc.

Chief Scientific Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 23, 2026Monte Rosa Therapeutics, Inc. (GLUE)Chief Scientific OfficerSale3,000$20.00$60,000
Jun 17, 2026Monte Rosa Therapeutics, Inc. (GLUE)Chief Scientific OfficerSale3,000$19.00$57,000
May 29, 2026Monte Rosa Therapeutics, Inc. (GLUE)Chief Scientific OfficerSale6,000$19.87$119,220